Creating, Managing and Responding to Risk in Cryptomarkets
This chapter examines the possible benefits that cryptomarkets have for harm reduction. The cryptomarket ecosystem is claimed as being transparent about drug quality and therefore benefiting both harm-reduction in illicit drug use and the establishment of a model for a legalised drug market. To that end, many market players seek to promote a rational, risk-reducing consumer-orientation to their actions. This chapter explores the significance for peer-supported harm-reduction. As with drug quality, risk and health are not agreed-on standards, but are dependent on how the drug is used. Some users do not seek to reduce their risk to the lowest possible level. Instead harm is expected and anticipated as a ‘necessary’ cost of drug use.
- Beckert, J., & Dewey, M. (2017). Introduction: The social organization of illegal markets. In J. Beckert & M. Dewey (Eds.), The architecture of illegal markets: Towards an economic sociology of illegality in the economy (pp. 1–34). Oxford: Oxford University Press. Retrieved from http://www.oxfordscholarship.com.ezproxy.is.ed.ac.uk/view/10.1093/oso/9780198794974.001.0001/oso-9780198794974.
- Bourgois, P., & Schonberg, J. (2009). Righteous dopefiend. University of California Press.Google Scholar
- Boucher, L. M., Marshall, Z., Martin, A., Larose-Hébert, K., Flynn, J. V., Lalonde, C., et al. (2017). Expanding conceptualizations of harm reduction: Results from a qualitative community-based participatory research study with people who inject drugs. Harm Reduction Journal, 14, 18. https://doi.org/10.1186/s12954-017-0145-2.
- Douglas, M. (1992). Risk and blame. Routledge.Google Scholar
- Duxbury, S. W., & Haynie, D. L. (2018). The network structure of opioid distribution on a darknet cryptomarket. Journal of Quantitative Criminology, 34(4), 921–941.Google Scholar
- Epstein, S. (1996). Impure science: AIDS, activism, and the politics of knowledge. Berkeley: University of California Press.Google Scholar
- Friedman, S. R., de Jong, W., Rossi, D., Touzé, G., Rockwell, R., Des Jarlais, D. C., et al. (2007). Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. International Journal of Drug Policy, 18(2), 107–117. https://doi.org/10.1016/j.drugpo.2006.11.006.CrossRefGoogle Scholar
- Harris, M., & Rhodes, T. (2012). Venous access and care: Harnessing pragmatics in harm reduction for people who inject drugs. Addiction, 107(6), 1090–1096.Google Scholar
- Hunt, G., Milhet, M., & Bergeron, H. (Eds.). (2011). Drugs and culture: Knowledge, consumption, and policy. Avebury: Ashgate.Google Scholar
- Lupton, D. (2015). Lively data, social fitness and biovalue: The intersections of health self-tracking and social media. New York: Social Science Research Network.Google Scholar
- Lupton, D. (2016). The quantified self: A sociology of self-tracking cultures. Cambridge: Polity.Google Scholar
- Munksgaard, R., Bakken, S., & Demant, J. (2017). Risk perception in emerging markets for illicit substances in Scandinavia-The effect of available information through online communities. The Scandinavian Research Council for Criminology.Google Scholar
- Soska, K., & Christin, N. (2015). Measuring the longitudinal evolution of the online anonymous marketplace ecosystem. In Proceedings of the 22nd USENIX Security Symposium. Presented at the USENIX Security 2015, Washington, DC.Google Scholar
- Van Hout, M. C., & Hearne, E. (2017). New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors. International Journal of Drug Policy, 40, 102–110.Google Scholar